Collaboration Details

Print  Close


Title of Collaborative Activity:

Urine biomarkers and risk of lung cancer in the Sisters Study

Description of Collaborative Activity:

The National Cancer Institute (NCI) is using urine samples from the Sisters study cohort National Institute of Environmental Health Sciences (NIEHS) and the laboratory resources of the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) funding to examine urine biomarkers of tobacco exposure and risk of lung cancer in a prospective study.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2019

NIH Participating Institutes/Centers/Office of the Director:

NCI

HHS Agency Collaborators on this Activity:

CDC, FDA